In vivo imaging of neuromodulation using positron emission tomography: Optimal ligand characteristics and task length for detection of activation

• Published in: Human brain mapping Vol. 3; no. 1; pp. 35 - 55
• Main Authors: Morris, Evan D., Fisher, Ronald E., Alpert, Nathaniel M., Rauch, Scott L., Fischman, Alan J.
• Format: Journal Article
• Language: English
• Published: Hoboken Wiley Subscription Services, Inc., A Wiley Company 1995; Wiley-Liss
• Subjects: activation; Biological and medical sciences; dopamine; endogenous; Investigative techniques, diagnostic techniques (general aspects); mathematical model; Medical sciences; Nervous system; optimization; Radionuclide investigations; receptor; Radionuclide study; Ligand binding; Dopamine; Central nervous system; Cognition; Catecholamine; Neuromodulation; D2 Dopamine receptor; Neuromediator; Simulation model; Mathematical model; Brain (vertebrata); Positron; Emission tomography
• ISSN: 1065-9471; 1097-0193
• DOI: 10.1002/hbm.460030105

Considerable evidence suggests that cognitive state affects local levels of neurotransmitter in the brain. We introduce a compartment model of neuroreceptor ligand kinetics to describe the effect of change in cognitive state on positron emission tomography (PET) signal dynamics. The model is used to establish optimal experimental conditions, timing of activation, and ligand characteristics, for detecting cognitive activation. The model, which follows free and bound endogenous neurotransmitter, describes the PET curve predicted for a single injection of radioligand in the presence or absence of activation. Activation was conceptualized as the performance of a task that raises the level of neurotransmitter that competes for receptor sites with the radioligand. Simulating the dopamine system, for example, required making assumptions regarding the kinetic rate constants for binding/dissociation of endogenous dopamine to/from the receptor and dopamine concentrations in the synapse. Simulations suggest that activation of dopamine should be detectable with PET and the D2 receptor ligand [11C]raclopride, although this ligand might not be optimal. Aspects of experimental design can be modified to optimize the likelihood of detecting neurotransmitter changes. The ideal radioligand for these studies should bind irreversibly to its receptor. Furthermore, the task should commence at injection time and last for at least 7 minutes. Optimal task duration depends on the dynamics of free radioligand in the tissue and can be determined via model simulations for any well‐characterized receptor ligand. Flow effects were shown to be distinguishable from those of neurotransmitter activation. General principles regarding desirable ligand characteristics and activation timing held for both the D2 receptor and the dopamine transporter site. © 1995 Wiley‐Liss, Inc.